Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025.
Second-quarter earnings, excluding special items, rose 1% year-over-year to $1.26 per share. On an unadjusted basis, net profit climbed to $1.27 billion or $0.99 per share in Q2 from $909 million or $0.68 per share in the same period of 2024.
All four operating segments registered growth in the October quarter, driving up total revenues to about $8.4 billion. The management expects organic revenue to grow 4.75-5.0% in fiscal 2025.
The post MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
